No record found


* Returns not adjusted for payouts
Company Profile
Citi Pharma Limited incorporated as a private limited company in Pakistan under the repealed Companies Ordinance, 1984 on October 08, 2012. The principal activity of the company is manufacturing and sale of pharmaceuticals, medical chemicals and botanical products.
Rizwan Ahmad | CEO |
Nadeem Amjad | Chairperson |
Ghulam Dastgeer | Company Secretary |
F.D Registrar Services (Pvt.) Ltd.
Aslam Malik & Co. Chartered Accountants
June
Equity Profile
Announcements
Date | Title | Document |
---|---|---|
Mar 3, 2025 | Transmission of Quarterly Financial Statements for the Half Year Ended 31 December 2024 | View PDF |
Feb 28, 2025 | Financial Results for the Quarter ended December 31, 2024 | View PDF |
Feb 12, 2025 | Half Yearly Progress Report for utilization of the proceeds for the half year ended December 31, 2023 | View PDF |
Feb 11, 2025 | Half Yearly Progress Report for utilization of the proceeds for the half year ended December 30, 2023 REVOKED | View PDF |
Feb 11, 2025 | Annual Progress Report for the year ended June 30, 2024 | View PDF |
Oct 31, 2024 | Transmission of Quarterly Report for the Period Ended | View PDF |
Oct 30, 2024 | Transmission of Quarterly Report for the Period Ended REVOKED | View PDF |
Oct 30, 2024 | Financial Results for the Quarter Ended | View PDF |
Oct 9, 2024 | Transmission of Annual Report for the Year Ended | View PDF |
Oct 2, 2024 | Financial Results for the year ended | View PDF |
Date | Title | Document |
---|---|---|
Apr 23, 2025 | Board Meeting | View |
Feb 21, 2025 | Board Meeting | View |
Feb 7, 2025 | Post meeting Briefing | View PDF |
Feb 7, 2025 | Decision of the Board Meeting Held on 2025-02-06 | View PDF |
Feb 6, 2025 | Board Meeting in Progress | View |
Jan 30, 2025 | Board Meeting Other Than Financial Results | View PDF |
Oct 30, 2024 | Board Meeting in Progress | View |
Oct 23, 2024 | Board Meeting | View |
Oct 7, 2024 | Notice of Annual General Meeting | View PDF |
Oct 1, 2024 | Board Meeting in Progress | View |
Sep 23, 2024 | Board Meeting | View |
Date | Title | Document |
---|---|---|
Apr 16, 2025 | EXTRACT OF RESOLUTION PASSED VIA CIRCULATION | View PDF |
Apr 16, 2025 | Material Information | View PDF |
Mar 27, 2025 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View |
Mar 26, 2025 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View |
Mar 4, 2025 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View PDF |
Feb 27, 2025 | Material Information | View PDF |
Jan 23, 2025 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View |
Dec 16, 2024 | Material Information | View PDF |
Dec 10, 2024 | Material Information | View PDF |
Dec 3, 2024 | Material Information | View PDF |
Nov 25, 2024 | Miscellaneous Information | View PDF |
Nov 22, 2024 | Miscellaneous Information REVOKED | View PDF |
Financials
All numbers in thousands (000's) except EPS
2024 | 2023 | 2022 | 2021 | |
---|---|---|---|---|
Sales | 12,409,239 | 12,396,983 | 9,779,880 | 5,795,404 |
Profit after Taxation | 833,464 | 657,984 | 635,884 | 351,768 |
EPS | 3.65 | 2.88 | 2.88 | 3.64 |
Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | |
---|---|---|---|---|
Sales | 3,534,432 | 3,224,645 | 3,558,874 | 3,275,165 |
Profit after Taxation | 256,979 | 201,497 | 211,345 | 375,601 |
EPS | 1.12 | 0.88 | 0.93 | 1.64 |

Ratios
2024 | 2023 | 2022 | 2021 | |
---|---|---|---|---|
Gross Profit Margin (%) | 12.78 | 12.16 | 13.83 | 13.47 |
Net Profit Margin (%) | 6.72 | 5.31 | 6.50 | 6.07 |
EPS Growth (%) | 26.74 | (20.88) | (88.58) | |
PEG | 0.29 | (0.54) | (0.11) |
Payouts
Date | Financial Results | Details | Book Closure |
---|---|---|---|
October 2, 2024 2:52 PM | 30/06/2024(YR) | 32.50%(F) (D) | 21/10/2024 - 28/10/2024 |
September 28, 2023 4:07 PM | 30/06/2023(YR) | 25%(F) (D) | 20/10/2023 - 27/10/2023 |
September 30, 2021 9:32 PM | 30/06/2021(YR) | 15% (D) - 10% (B) | 21/10/2021 - 28/10/2021 |